SCHEMBL17366903

SCHEMBL17366903

CC1(C)C2=C(c3ccccc31)C(C)(C)c1c2ccc2c3ccccc3n(-c3nc(-c4ccccc4)c4ccccc4n3)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ HPGD P15428 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ POLB P06746 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ KMT2A Q03164 3/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ NUDT1 P36639 3/20 0.32
▸ DUSP3 P51452 1/20 0.32
▸ PRKCB P05771 3/20 0.32
▸ PRKCA P17252 3/20 0.32
▸ PRKCH P24723 3/20 0.32
▸ PRKCE Q02156 3/20 0.32
▸ PRKCQ Q04759 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18505568 0.89 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL17427632 0.86 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL20438181 0.85 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL22959434 0.85 ALDH1A1 (0.37) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL17299544 0.83 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL22959437 0.83 L3MBTL1 (0.36) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL18014965 0.83 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL21588671 0.83 ALDH1A1 (0.42) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL19421259 0.82 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL15860804 0.82 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 — — US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 — — US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 ALDH1A1 13/4885L3MBTL1 717/4885KDM4E 3404/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 ALDH1A1 13/4885L3MBTL1 717/4885KDM4E 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback